Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy

World Journal of Gastroenterology

Volumn 19, Issue 10, 2013, Pages 1639-1644

  Chen, Chuang Zhen ^a   Chen, Jian Zhou ^a   Li, De Rui ^a   Lin, Zhi Xiong ^a   Zhou, Ming Zhen ^a   Li, Dong Sheng ^a   Chen, Zhi Jian ^a  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Esophageal neoplasm; Multivariate analysis; Prognostic factor; Three dimensional conformal radiotherapy

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; THORAX; TUMOR VOLUME;

EID: 84875331712     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i10.1639     Document Type: Article

References (25)

1. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-1627 [PMID: 10235156 DOI: 10.1001/jama.281.17.1623]
2. Chen ZJ, Chen CZ, Li DS, Zhang PC, Li DR. Comparison of CT simulation with conventional simulation in the treatment planning of esophageal carcinoma. Zhonghua Fangshe Zhongliu Xue Zazhi 2001; 10: 85-87
3. Guzel Z, Bedford JL, Childs PJ, Nahum AE, Webb S, Oldham M, Tait D. A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress. Br J Radiol 1998; 71: 1076-1082 [PMID: 10211069]
4. Wu VW, Sham JS, Kwong DL. Inverse planning in threedimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol 2004; 77: 568-572 [PMID: 15238403 DOI: 10.1259/bjr/19972578]
5. Komaki R, Liao Z, Forster K, Lee HK, Stevens CW, Cox JD. Target definition and contouring in carcinoma of the lung and esophagus. Rays 2003; 28: 225-236 [PMID: 15018311]
6. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007; 17: 2-9 [PMID: 17185192 DOI: 10.1016/j.semradonc.2006.09.003]
7. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004; 31: 450-464 [PMID: 15297938 DOI: 10.1053/j.seminoncol.2004.04.021]
8. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-1168 [PMID: 17401004 DOI: 10.1200/JCO.2005.04.7118]
9. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-1733 [PMID: 12049861 DOI: 10.1016/S0140-6736(02)08651-8]
10. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317 [PMID: 15800321 DOI: 10.1200/JCO.2005.00.034]
11. Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J, Maughan TS. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004; 90: 70-75 [PMID: 14710209 DOI: 10.1038/sj.bjc.6601461]
12. Gwynne S, Hurt C, Evans M, Holden C, Vout L, Crosby T. Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol) 2011; 23: 182-188 [PMID: 21232928 DOI: 10.1016/j.clon.2010.12.001]
13. Iizuka T, Isono K, Kakegawa T, Watanabe H. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases. Chest 1989; 96: 1005-1011 [PMID: 2805827 DOI: 10.1378/chest.96.5.1005]
14. Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer 1988; 61: 2310-2314 [PMID: 3284634 DOI: 10.1002/1097-0142(19880601)]
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago, IL: Springer, 2010
16. Rice TW, Rusch VW, Blackstone EH. 2009 AJCC/UICC staging of esophageal cancer. In: Shields TW, Locicero J, Reed CE, Feins RH, eds. General thoracic surgery. 7th ed. Vol 2. Amsterdam, Netherlands: Wolters Kluwer, 2009: 2013-2015
17. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007; 245: 717-725 [PMID: 17457164 DOI: 10.1097/01.sla.0000251703.35919.02]
18. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-1443 [PMID: 12237911 DOI: 10.1002/cncr.10868]
19. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol 2006; 93: 258-267 [PMID: 16496364 DOI: 10.1002/ jso.20449]
20. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2009; 138: 831-836 [PMID: 19660349 DOI: 10.1016/j.jtcvs.2009.02.003]
21. Wang L, Han C, Zhang X, Wang J, Ma GX, Xiao AQ. Multivariate analysis of three dimensional conformal radiotherapy for esophageal carcinoma. Zhonghua Zhongliu Fangzhi Zazhi 2009; 16: 58-61
22. Mariette C, Piessen G, Briez N, Triboulet JP. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008; 247: 365-371 [PMID: 18216546 DOI: 10.1097/SLA.0b013e31815aaadf]
23. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 2008; 248: 221-226 [PMID: 18650631 DOI: 10.1097/SLA.0b013e31817bbe59]
24. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008; 248: 549-556 [PMID: 18936567DOI: 10.1097/SLA.0b013e318188c474]
25. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-413 [PMID: 8173915 DOI: 10.1002/bjs.1800810330]